Unilever to market weight-loss shots
Unilever will be expanding its weight management products by making them quicker to consume.
Peter Haring, Unilever’s global research and development director for Slimfast, had revealed that while the it is difficult to develop weight management food and beverage products, one idea Unilever was to market a “drinkable shot,” similar to the company’s weight loss product Slimfast, Food Navigation U.S.A. reports.
In 2004, Unilever relaunched Slimfast, which included an expanded line of products under the Slimfast Optima diet range. According to Haring, the active satiety ingredient of this formulation is fiber.
An example of such shots is Unilever’s present line of Vitality shots for cholesterol control. Haring suggested a weight management approach could be blended into a cholesterol line like this one.
Although Unilever plans to take make their said global marketing initiative across the world, Haring said there will be “some more attention [give] to the U.S. because of its important weight management market and developed dietary supplement market.”
Unilever has held the rights to Phytopharm’s hoodia extract, P57, for the last couple of years, and is involved in extensive research aimed at the use of this in food products.
According to Food Navigation U.S.A., the U.S. weight management market is said to be the world’s largest, since one-third of Americans are obese. Haring hinted that Unilever is developing weight management products in other formats, but had not discussed that matter further.
Other than Slimfast, Unilever also markets teas for weight management, particularly in Europe and Japan, as well as soups (mainly in Europe).
Judge dismisses important J&J claim in Red Cross case
WASHINGTON A federal judge on Monday dismissed an important part of the lawsuit brought by Johnson & Johnson against the American Red Cross seeking to restrict the Red Cross’s use of its emblem on first aid, health, safety and emergency preparedness products, the Red Cross announced Tuesday.
The judge’s ruling dismissed entirely the J&J claim that the Red Cross promised not to engage in the sale of first aid, health, safety and emergency preparedness products.
“I appreciate the court’s decision and hope that Johnson & Johnson will reassess their actions and drop the case altogether,” stated Mark Everson, president and chief executive officer of the American Red Cross. “As the recent wildfires in California demonstrated, the Red Cross has an important mission to perform, and we want to put this distraction behind us and do the work the American people expect us to do.”
Following a hearing on Monday, Oct. 29, at the United States District Court for the Southern District of New York, Judge Jed Rakoff ruled that the “promissory estoppel” claim, a very significant portion of the pharmaceutical company’s lawsuit against the Red Cross, was “dismissed with prejudice.” The judge’s ruling also means that J&J cannot refile arguments on this claim.
The judge’s order comes nearly three months after J&J filed suit against the Red Cross for the Red Cross’ use of its emblem on products it sells to the public.
The court has set a schedule for hearing the remaining claims early next year.
Lil’ Drug Store signs exclusivity deal with Carmex
CEDAR RAPIDS, Iowa Lil’ Drug Store has been chosen to be the exclusive distributor of Carmex Lip Balm to the convenience class of trade, the company announced Wednesday.
“With over 140,000 convenience stores nationwide, this is a major opportunity for both Lil’ Drug and Carma,” stated Mike Pietsch, vice president of sales and marketing for Carma Laboratories, which distributes Carmex.